Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Others target fat mobilization directly
Active gallbladder disease Starting tirzepatide during active gallbladder symptoms is generally not recommended
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist licensed in the UK for the treatment of type 2 diabetes mellitus and for weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
When injected, it binds to GHRH receptors on the pituitary and triggers a pulse of growth hormone release, which in turn drives the production of IGF-1 (insulin-like growth factor 1), the downstream hormone responsible for most of growth hormones tissue effects
Aliquot your reconstituted solution into smaller, single-use vials if you don't plan to use the entire batch quickly
Kidney problems (kidney failure): In people who have kidney problems, diarrhoea, nausea, and vomiting may cause a loss of fluids (dehydration,) which may cause kidney problems to get worse
US$ 21.75
US$ 23.92
US$ 24.90
US$ 28.11
US$ 29.23
